Fetal and neonatal DA was studied with Wistar rats; sulfonylurea drugs including tolbutamide, chlorpropamide, gliclazide, glimepiride, and glibenclamide (K ATP channel inhibitors); diazoxide and pinacidil (K ATP channel openers, KCOs); and rapid whole-body freezing (Fig. 37.1) .
closed the fetal DA dose-dependently with direct fetal injection. Fetal DA closure was associated with hydrops and fetal death.
Diazoxide and pinacidil delayed DA closure following neonatal injection immediately postnatally and dilated the closing DA with injection at 60 min postnatally.
All tested sulfonylurea drugs constricted fetal DA dose-dependently and with complete closure at large doses. KCOs dilated the neonatal DA. These results indicate physiological regulation of fetal and neonatal DA with K ATP channels.
This study has several clinical implications. Sulfonylurea-associated fetal death was first reported 50 years ago. The mechanism of death remained unclear prior to this study. Sulfonylureas may be useful for closing patent DA in premature neonates.
Recently reported neonatal DA reopening associated with the use of diazoxide for hyperinsulinemic hypoglycemia has been proved experimentally. DA-dilating effect of KCO drugs may be useful as a bridge to surgery in neonatal DA-dependent congenital heart diseases.
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The images or other third party material in this chapter are included in the work's Creative Commons license, unless indicated otherwise in the credit line; if such material is not included in Fig. 37.1 The fetal ductus arteriosus was studied in the near-term fetus or newborn rat following rapid whole-body freezing, cutting on the freezing microtome, with a microscope and a micrometer. The control fetus shows a widely open ductus (a), and the fetus with glibenclamide (10 mg/kg; 10-100 times clinical dose injected at 1 h before) shows severely constricted ductus (b). AA aortic arch, DA ductus arteriosus, LA left atrium, LPA left pulmonary artery, LSVC left superior vena cava, RPA right pulmonary artery, T thymus the work's Creative Commons license and the respective action is not permitted by statutory regulation, users will need to obtain permission from the license holder to duplicate, adapt or reproduce the material.
